Abstract
Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327:138-50. 35015037.
Publication types
-
Randomized Controlled Trial
-
Comment
MeSH terms
-
Adult
-
Diabetes Mellitus*
-
Diabetes Mellitus, Type 2* / drug therapy
-
Double-Blind Method
-
Glucagon-Like Peptides
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Injections, Subcutaneous
-
Liraglutide / adverse effects
-
Obesity / complications
-
Obesity / drug therapy
-
Overweight / complications
-
Weight Gain
-
Weight Loss
Substances
-
Hypoglycemic Agents
-
semaglutide
-
Glucagon-Like Peptides
-
Liraglutide